Association between small apolipoprotein(a) isoforms and frontotemporal dementia in humans

被引:9
作者
Emanuele, E
Peros, E
Tomaino, C
Feudatari, E
Bernardi, L
Binetti, G
Maletta, R
Micieli, G
Bruni, AC
Geroldi, D
机构
[1] Univ Pavia, Mol Med Lab, IRCCS, Policlin San Matteo, I-27100 Pavia, Italy
[2] Univ Pavia, IRCCS Casimiro Mondino, Dept Neurol, I-27100 Pavia, Italy
[3] Ctr San Giovanni di Dio, FBF, IRCCS, Memory Clin, Brescia, Italy
[4] Ctr San Giovanni di Dio, FBF, IRCCS, Neurobiol Lab, Brescia, Italy
[5] Reg Ctr Neurogenet, Lamezia Terme, CZ, Italy
[6] Univ Pavia, Policlin San Matteo, IRCCS, Dept Internal Med & Med Therapeut, I-27100 Pavia, Italy
关键词
apolipoprotein(a) isoforms; frontotemporal dementia; susceptibility; biomarkers;
D O I
10.1016/j.neulet.2003.09.046
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Apolipoprotein(a) [apo(a)] is a genetically polymorphic glycoprotein that has several similarities to apolipoprotein E. However, its role as a risk factor for frontotemporal dementia (FTD) remains to be elucidated. We therefore investigated the effect of an apo(a) polymorphism on the incidence of FTD in a sample of Caucasian Italian patients. From the entire group of FTD patients (n = 54), 55.6% of the subjects had at least one apo(a) low molecular weight (MW) isoform, compared to 29.9% of non-demented controls (n = 77). The difference between the two groups was statistically significant (odds ratio 2.93, 95% confidence interval 1.42-6.06, P = 0.003). The FTD group was further divided into sporadic (n = 26) and familial (n = 28) cases. Even after such dichotomization, both sporadic and familial FTD patients showed a significantly higher prevalence of low MW apo(a) isoforms than the cognitively healthy controls (P = 0.011 and P = 0.025, respectively). Our data suggest a role of apo(a) phenotypes of low MW in mediating susceptibility to FTD. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:201 / 204
页数:4
相关论文
共 23 条
  • [1] The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor
    Argraves, KM
    Kozarsky, KF
    Fallon, JT
    Harpel, PC
    Strickland, DK
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) : 2170 - 2181
  • [2] APOLIPOPROTEIN(A) GENE ACCOUNTS FOR GREATER THAN 90-PERCENT OF THE VARIATION IN PLASMA LIPOPROTEIN(A) CONCENTRATIONS
    BOERWINKLE, E
    LEFFERT, CC
    LIN, JP
    LACKNER, C
    CHIESA, G
    HOBBS, HH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) : 52 - 60
  • [3] Lipoprotein(a) and inflammation in human coronary atheroma: Association with the severity of clinical presentation
    Dangas, G
    Mehran, R
    Harpel, PC
    Sharma, SK
    Marcovina, SM
    Dube, G
    Ambrose, JA
    Fallon, JT
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (07) : 2035 - 2042
  • [4] Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age
    Gazzaruso, C
    Garzaniti, A
    Buscaglia, P
    Bonetti, G
    Falcone, C
    Fratino, P
    Finardi, G
    Geroldi, D
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (01) : 157 - 163
  • [5] CHARACTERIZATION OF APO(A) POLYMORPHISM BY A MODIFIED IMMUNOBLOTTING TECHNIQUE IN AN ITALIAN POPULATION-SAMPLE
    GEROLDI, D
    BELLOTTI, V
    BUSCAGLIA, P
    BONETTI, G
    GAZZARUSO, C
    CAPRIOLI, A
    FRATINO, P
    [J]. CLINICA CHIMICA ACTA, 1993, 221 (1-2) : 159 - 169
  • [6] The apolipoprotein E ε4 allele is not a significant risk factor for frontotemporal dementia
    Geschwind, D
    Karrim, J
    Nelson, SF
    Miller, B
    [J]. ANNALS OF NEUROLOGY, 1998, 44 (01) : 134 - 138
  • [7] Tau mutations cause frontotemporal dementias
    Goedert, M
    Crowther, RA
    Spillantini, MG
    [J]. NEURON, 1998, 21 (05) : 955 - 958
  • [8] LIPOPROTEIN(A) SERUM CONCENTRATION AND APOLIPOPROTEIN(A) PHENOTYPE CORRELATE WITH SEVERITY AND PRESENCE OF ISCHEMIC CEREBROVASCULAR-DISEASE
    JURGENS, G
    TADDEIPETERS, WC
    KOLTRINGER, P
    PETEK, W
    CHEN, Q
    GREILBERGER, J
    MACOMBER, PF
    BUTMAN, BT
    STEAD, AG
    RANSOM, JH
    [J]. STROKE, 1995, 26 (10) : 1841 - 1848
  • [9] KAMBOH MI, 1991, AM J HUM GENET, V49, P1063
  • [10] Koch M, 1997, J AM SOC NEPHROL, V8, P1889